Dr. Akin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
39901 Traditions Dr
Northville, MI 48168Phone+1 248-305-4400Fax+1 248-305-4401
Education & Training
National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1996 - 1999
University of Louisville School of MedicineResidency, Internal Medicine, 1993 - 1996
Istanbul University FomClass of 1988
Certifications & Licensure
MI State Medical License 2003 - 2027
MA State Medical License 2009 - 2017
MD State Medical License 1996 - 2004- American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Super Doctor SuperDoctors.com
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Molecular Mechanisms and Diagnosis of Mastocytosis Start of enrollment: 2004 Jul 01
- Clonal Mast Cell Disorders in Exercise-Induced Anaphylaxis Start of enrollment: 2011 Mar 01
Publications & Presentations
PubMed
- 8 citationsDeveloping a standardized approach for assessing mast cells and eosinophils on tissue biopsies: A Work Group Report of the AAAAI Allergic Skin Diseases Committee.Nives Zimmermann, J. Pablo Abonia, Stephen C. Dreskin, Cem Akin, Scott Bolton
The Journal of Allergy and Clinical Immunology. 2021-10-01 - 426 citationsCharacterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation followin...Arnold S. Kirshenbaum, Cem Akin, Yalin Wu, Menachem Rottem, Julie P. Goff
Leukemia Research. 2003-08-01 - 3 citationsTyrosine Kinase Inhibitors in Non-advanced Systemic Mastocytosis.Cem Akin
Immunology and Allergy Clinics of North America. 2023-11-01
Lectures
- Pioneer: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Avapritinib in Patients with Indolent or Smoldering Systemic Mastocytosis with Symptoms Inade...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Other
- Original Article the Mastocytosis Society Survey on Mast Cell Disorders: Part 2-Patient Clinical Experiences and BeyondCem Akin, MD, ScienceDirect
https://www.doximity.com/articles/b432751a-ab97-4bd1-babc-759b194081d6
UpToDate, Wolters Kluwer Health - 2013-02-08 - Original Article the Mastocytosis Society Survey on Mast Cell Disorders: Part 2-Patient Clinical Experiences and BeyondCem Akin, MD, ScienceDirect
https://www.doximity.com/articles/b432751a-ab97-4bd1-babc-759b194081d6
UpToDate, Wolters Kluwer Health - 2012-05-11 - Original Article the Mastocytosis Society Survey on Mast Cell Disorders: Part 2-Patient Clinical Experiences and BeyondCem Akin, MD, ScienceDirect
https://www.doximity.com/articles/b432751a-ab97-4bd1-babc-759b194081d6
UpToDate, Wolters Kluwer Health - 2012-11-19 - Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
